Equol

DB11674InvestigationalSmall molecule

Equol has been used in trials studying the treatment of Breast Cancer.

Mechanism: Pharmacologically active on Estrogen receptor beta
Curator reviewed
Formula / weight: C₁₅H₁₄O₃ · 242.2699 g/mol (avg)
Also known as: S-equol

Resolves to

Compound

Clinical / RWD

Structure

InChIKeyADFCQWZHKCXPAJ-GFCCVEGCSA-NSMILESOC1=CC=C(C=C1)[C@H]1COC2=C(C1)C=CC(O)=C2

Targets

What you can answer from here — as of April 02, 2025

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

557Drug interactionsStructured to mechanism, not free text

10Clinical trialsPhase, status and sponsor resolved per trial

5+ReferencesStructured and connected to the statements they support

Which drugs share a target with Equol, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.